LoginSignup
Syneos Health logo

Syneos Health

Stock
Stock
ISIN: US87166B1026
Ticker: SYNH
US87166B1026
SYNH

Price

Price

CHART BY

Frequently asked questions

What is the Earnings Per Share (EPS) for Syneos Health?

Syneos Health's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.691. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Syneos Health's stock?

Currently, 1 analysts cover Syneos Health's stock, with a consensus target price of $43.00. Analyst ratings provide insights into the stock's expected performance.

What is Syneos Health's revenue over the trailing twelve months?

Over the trailing twelve months, Syneos Health reported a revenue of $5.42B.

What is the EBITDA for Syneos Health?

Syneos Health's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $587.42M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Syneos Health?

Syneos Health has a free cash flow of $161.92M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

How many employees does Syneos Health have, and what sector and industry does it belong to?

Syneos Health employs approximately 29,395 people. It operates in the Health Care sector, specifically within the Biotechnology industry.

Financials

EPS (TTM) 
$0.691
Revenue (TTM) 
$5.42B
EBITDA (TTM) 
$587.42M
Free Cashflow (TTM) 
$161.92M

Analyst Ratings

The price target is $43.00 and the stock is covered by 1 analysts.

Buy

0

Hold

1

Sell

0

Information

Syneos Health, Inc. engages in the provision of biopharmaceutical solutions. It operates through the Clinical Solutions and Commercial Solutions segments. The Clinical Solutions segment offers global services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics that span Phase I to IV of clinical development. It also offers individual services including regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health services, clinical trial diversity, biometrics, and regulatory affairs. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, and consultancy services. The company was founded in 1998 and is headquartered in Morrisville, NC.

Employees
29,395
Industries
Biotechnology
Sector
Health Care

Identifier

ISIN
US87166B1026
Primary Ticker
SYNH
Join the conversation
Sign upLogin